Clinical Trial Update: Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

View source ↗

Summary

This completed trial updates on immune-related adverse events in cancer patients undergoing immunotherapy and explores associated biomarkers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Duke University | Conditions: Cancer, Immune-related Adverse Event | Status: COMPLETED